Live Breaking News & Updates on Kiki patel

Stay informed with the latest breaking news from Kiki patel on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Kiki patel and stay connected to the pulse of your community

Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update

Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Kiki-patel , James-levine , Taft-communications , Nasdaq , Cardiff-oncology-inc , Globenewswire-inc , Gilmartin-group , Oncology-contact ,

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study

RAS-mutated mCRC– In RAS-mutated mCRC, novel preclinical finding demonstrates onvansertib inhibits the tumor’s ability to adapt to hypoxia resulti...

San-diego , California , United-states , American , James-levine , Kiki-patel , Mark-erlander , Nasdaq , American-association-for-cancer-research , Online-program , Gilmartin-group , Taft-communications

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

California , United-states , San-diego , American , James-levine , Kiki-patel , Mark-erlander , Taft-communications , Gilmartin-group , American-association-for-cancer-research , Nasdaq , Online-program

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

California , United-states , San-diego , American , Mark-erlander , Kiki-patel , American-association-for-cancer-research , Grace-spencertaft-communications , Cardiff-oncology-inc , Pharmd-gilmartin-group , Nasdaq , American-association

Immuneering Appoints Thomas J. Schall, Ph.D. to its Board of Directors

CAMBRIDGE, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develo...

Cambridge , Cambridgeshire , United-kingdom , Gina-nugent , Laurence-watts , Kiki-patel , Ben-zeskind , Thomasj-schall , Schering , Stanford-university , Plough-corporation , Chemocentryx-inc

Immuneering Doses First Patient in Phase 2a Clinical Trial of IMM-1-104 in RAS-mutant Solid Tumors

- First patient dosed with IMM-1-104 in combination with modified gemcitabine plus nab-paclitaxel for first-line treatment of pancreatic ductal adenocarcinoma - - Phase 2a portion of Phase 1/2a...

Cambridge , Cambridgeshire , United-kingdom , United-states , Gina-nugent , Laurence-watts , Ben-zeskind , Kiki-patel , Nugent-communications , Immuneering-corporation , Gilmartin-group , Exchange-commission

Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in ...

-New clinical datafrom second-line randomized ONSEMBLE trial provides further evidence of the efficacy of onvansertib in combination with FOLFIRI/bev in bev naïve RAS-mutated mCRC patients -

Richa-kumari , Kiki-patel , James-levine , Fairooz-kabbinavar , Cardiff-oncology-inc , Gilmartin-group , Exchange-commission , Nasdaq , Taft-communications , Chief-medical-officer , Cardiff-oncology , Objective-response-rates

Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United-states , American , James-levine , Kiki-patel , Mark-erlander , Richa-kumari , Nasdaq , Taft-communications , Exchange-commission , Gilmartin-group , Clinical-cancer-research , Pfizer

Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRC

Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRC
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

James-levine , Fairooz-kabbinavar , Kiki-patel , Richa-kumari , Nasdaq , Taft-communications , Cardiff-oncology-inc , Exchange-commission , Gilmartin-group , Oncology-provides-clinical-update , Chief-medical-officer , Cardiff-oncology

Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRC

Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRC
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Bev-exposedpatients , Fairooz-kabbinavar , Kiki-patel , Nasdaq , Exchange-commission , Richa-kumaritaft-communications , Pharmdgilmartin-group , Cardiff-oncology-inc , Chief-medical-officer , Cardiff-oncology , Objective-response-rates , Emergent-adverse-events